Literature DB >> 17215581

Insulin-like growth factor-1, leptin, body composition, and clinical status interactions in children with cystic fibrosis.

Margaret C S Boguszewski1, Tsukiyo Obu Kamoi, Rosana Bento Radominski, Cesar Luiz Boguszewski, Sten Rosberg, Nelson Augusto Rosário Filho, Romolo Sandrini Neto, Kerstin Albertsson-Wikland.   

Abstract

BACKGROUND/AIMS: Children with cystic fibrosis (CF) are of increased risk of reduced fat body mass (FBM) and lean body mass (LBM). Serum concentrations of insulin-like growth factor-1 (IGF-1)and leptin could be markers of LBM and/or FBM depletion. To evaluate the relationships between disease activity, body composition, IGF-1 and leptin concentrations in CF children.
METHODS: A cross-sectional study with 26 CF children aged 5.0-15.5 years and 33 healthy controls, mean age 9.4 years. Body composition was evaluated by dual-energy X-ray absorptiometry. Fasting blood samples were analyzed for leptin, IGF-1 and IGFBP-3.
RESULTS: FBM standard deviation score (SDS; CF boys -0.02 +/- 0.88 vs. 0.78 +/- 0.65, p < 0.01; CF girls -0.37 +/- 1.15 vs. 0.70 +/- 0.97, p < 0.05), leptin concentration (CF boys 2.07 +/- 0.79 vs. 3.07 +/- 1.28 ng/ml, p < 0.05; CF girls 2.71 +/- 0.86 vs. 5.00 +/- 2.95 ng/ml, p < 0.05) and IGF-1SDS (CF boys -1.43 +/- 1.50 vs. -0.32 +/- 0.88, p < 0.05; CF girls -0.66 +/- 1.66 vs. 0.64 +/- 0.57, p < 0.01) were lower in CF children compared to controls. Shwachman score was the strongest predictor of lean body mass (R = 0.63). Leptin levels explain 60% of the variability in FBM.
CONCLUSION: Serum concentrations of IGF-1 and leptin are decreased in children with CF and are associated with clinical conditions and body composition. Copyright (c) 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17215581     DOI: 10.1159/000098480

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  10 in total

1.  Absence of leptin signaling allows fat accretion in cystic fibrosis mice.

Authors:  Ilya R Bederman; Gavriella Pora; Maureen O'Reilly; James Poleman; Kimberly Spoonhower; Michelle Puchowicz; Aura Perez; Bernadette O Erokwu; Alex Rodriguez-Palacios; Chris A Flask; Mitchell L Drumm
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-08-17       Impact factor: 4.052

2.  Estrogen sulfotransferase in the metabolism of estrogenic drugs and in the pathogenesis of diseases.

Authors:  Anne Caroline S Barbosa; Ye Feng; Chaohui Yu; Min Huang; Wen Xie
Journal:  Expert Opin Drug Metab Toxicol       Date:  2019-03-18       Impact factor: 4.481

3.  Circulating brain-derived neurotrophic factor, leptin, neuropeptide Y, and their clinical correlates in cystic fibrosis: a cross-sectional study.

Authors:  Jan K Nowak; Mariusz Szczepanik; Magdalena Trypuć; Andrzej Pogorzelski; Waldemar Bobkowski; Marcin Grytczuk; Alina Minarowska; Rafał Wójciak; Jaroslaw Walkowiak
Journal:  Arch Med Sci       Date:  2018-04-23       Impact factor: 3.318

4.  Serum insulin-like growth factor-1 (IGF-1) during CF pulmonary exacerbation: trends and biomarker correlations.

Authors:  A H Gifford; A B Nymon; A Ashare
Journal:  Pediatr Pulmonol       Date:  2013-06-18

5.  Increased SULT1E1 activity in HepG2 hepatocytes decreases growth hormone stimulation of STAT5b phosphorylation.

Authors:  Li Li; Dongning He; Teresa W Wilborn; Josie L Falany; Charles N Falany
Journal:  Steroids       Date:  2008-09-11       Impact factor: 2.668

6.  Growth failure and treatment in cystic fibrosis.

Authors:  Trang N Le; Abeer Anabtawi; Melissa S Putman; Vin Tangpricha; Michael S Stalvey
Journal:  J Cyst Fibros       Date:  2019-10       Impact factor: 5.482

7.  Serum leptin and neuropeptide Y in patients with cystic fibrosis-A single center study.

Authors:  Sabina Galiniak; Rafał Podgórski; Marta Rachel; Artur Mazur
Journal:  Front Med (Lausanne)       Date:  2022-09-14

8.  The association between body composition, leptin levels and glucose dysregulation in youth with cystic fibrosis.

Authors:  Andrea Granados; Elizabeth A Beach; Andrew J Christiansen; Bruce W Patterson; Michael Wallendorf; Ana María Arbeláez
Journal:  J Cyst Fibros       Date:  2021-06-26       Impact factor: 5.527

9.  Variation in plasma leptin levels in young Iranian children with cystic fibrosis.

Authors:  Maryam Monajemzadeh; Mohammad Taghi Haghi Ashtiani; Ehsan Sadrian; Sedigheh Shams; Farzaneh Motamed; Mehri Najafi Sani; Setareh Sadat Banihosseini; Ata Abbasi
Journal:  Arch Med Sci       Date:  2013-11-05       Impact factor: 3.318

10.  Adiponectin Expression Is Modulated by Long-Term Physical Activity in Adult Patients Affected by Cystic Fibrosis.

Authors:  Rita Polito; Ersilia Nigro; Ausilia Elce; Maria Ludovica Monaco; Paola Iacotucci; Vincenzo Carnovale; Marika Comegna; Monica Gelzo; Federica Zarrilli; Gaetano Corso; Giuseppe Castaldo; Aurora Daniele
Journal:  Mediators Inflamm       Date:  2019-09-09       Impact factor: 4.711

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.